Movement Alert｜UnitedHealth Rises 3.01% in Regular Trading, Multiple Investment Banks Raise Target Prices Post-Q2 Earnings

Market Focus07-22

On July 21, UnitedHealth rose 3.01% in regular trading, trading at $434.24/share, with turnover of $720 million. The stock continued to gain momentum as Wall Street firms collectively raised their target prices following the company's strong Q2 earnings report.

On the day, Mizuho raised its target price from $470 to $493, while Barclays raised its target to $441. Earlier, Morgan Stanley significantly raised its target to $529, Bank of America to $512, Jefferies to $490, Piper Sandler to $499, and RBC to $478. The consensus mean target price now stands at approximately $477.80 according to FactSet.

The upgrades follow UnitedHealth's Q2 results released on July 16, which showed adjusted EPS of $6.38, beating the consensus estimate of $4.86 by over 31%. Revenue came in at $112 billion, also exceeding expectations. The company simultaneously raised its full-year adjusted EPS guidance to $19.50-$20.00, well above the prior outlook of greater than $18.25 and the Street consensus of $18.49. Management also announced plans for at least $5 billion in share repurchases for the full year.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1166445004?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-22 00:31","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1166445004","market":"us","top_or_hot":-1,"title":"Movement Alert｜UnitedHealth Rises 3.01% in Regular Trading, Multiple Investment Banks Raise Target Prices Post-Q2 Earnings","media":"Market Focus","content":"<p><p>On July 21, UnitedHealth rose 3.01% in regular trading, trading at $434.24/share, with turnover of $720 million. The stock continued to gain momentum as Wall Street firms collectively raised their target prices following the company's strong Q2 earnings report.</p><p>On the day, Mizuho raised its target price from $470 to $493, while Barclays raised its target to $441. Earlier, Morgan Stanley significantly raised its target to $529, Bank of America to $512, Jefferies to $490, Piper Sandler to $499, and RBC to $478. The consensus mean target price now stands at approximately $477.80 according to FactSet.</p><p>The upgrades follow UnitedHealth's Q2 results released on July 16, which showed adjusted EPS of $6.38, beating the consensus estimate of $4.86 by over 31%. Revenue came in at $112 billion, also exceeding expectations. The company simultaneously raised its full-year adjusted EPS guidance to $19.50-$20.00, well above the prior outlook of greater than $18.25 and the Street consensus of $18.49. Management also announced plans for at least $5 billion in share repurchases for the full year.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜UnitedHealth Rises 3.01% in Regular Trading, Multiple Investment Banks Raise Target Prices Post-Q2 Earnings</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜UnitedHealth Rises 3.01% in Regular Trading, Multiple Investment Banks Raise Target Prices Post-Q2 Earnings\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-07-22 00:31</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On July 21, UnitedHealth rose 3.01% in regular trading, trading at $434.24/share, with turnover of $720 million. The stock continued to gain momentum as Wall Street firms collectively raised their target prices following the company's strong Q2 earnings report.</p><p>On the day, Mizuho raised its target price from $470 to $493, while Barclays raised its target to $441. Earlier, Morgan Stanley significantly raised its target to $529, Bank of America to $512, Jefferies to $490, Piper Sandler to $499, and RBC to $478. The consensus mean target price now stands at approximately $477.80 according to FactSet.</p><p>The upgrades follow UnitedHealth's Q2 results released on July 16, which showed adjusted EPS of $6.38, beating the consensus estimate of $4.86 by over 31%. Revenue came in at $112 billion, also exceeding expectations. The company simultaneously raised its full-year adjusted EPS guidance to $19.50-$20.00, well above the prior outlook of greater than $18.25 and the Street consensus of $18.49. Management also announced plans for at least $5 billion in share repurchases for the full year.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"UNH","symbol_name":"联合健康","start_time":0,"source_url":"","article_id":"1166445004","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1166445004","pubTimestamp":1784651483,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On July 21, UnitedHealth rose 3.01% in regular trading, trading at $434.24/share, with turnover of $720 million. The stock continued to gain momentum as Wall Street firms collectively raised their...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"UNH":"联合健康"},"translate_title":"走势警报|UnitedHealth 常规交易中上涨 3.01%，多家投资银行在第二季度盈利后上调目标价","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"UNH":1},"content_text":"On July 21, UnitedHealth rose 3.01% in regular trading, trading at $434.24/share, with turnover of $720 million. The stock continued to gain momentum as Wall Street firms collectively raised their target prices following the company's strong Q2 earnings report.On the day, Mizuho raised its target price from $470 to $493, while Barclays raised its target to $441. Earlier, Morgan Stanley significantly raised its target to $529, Bank of America to $512, Jefferies to $490, Piper Sandler to $499, and RBC to $478. The consensus mean target price now stands at approximately $477.80 according to FactSet.The upgrades follow UnitedHealth's Q2 results released on July 16, which showed adjusted EPS of $6.38, beating the consensus estimate of $4.86 by over 31%. Revenue came in at $112 billion, also exceeding expectations. The company simultaneously raised its full-year adjusted EPS guidance to $19.50-$20.00, well above the prior outlook of greater than $18.25 and the Street consensus of $18.49. Management also announced plans for at least $5 billion in share repurchases for the full year.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"shareholding,dataReport","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.46.0","shortVersion":"4.46.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1166445004","isCrawlerRequest":true}